Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes.
about
Improving clinical outcomes for naltrexone as a management of problem alcohol usePharmacogenetics of OPRM1.Genetic influences on response to alcohol and response to pharmacotherapies for alcoholism.Network analysis of the genomic basis of the placebo effect.The effects of alcohol on the pharmacokinetics and pharmacodynamics of the selective mu-opioid receptor antagonist GSK1521498 in healthy subjectsAssociations of OPRM1 A118G and alcohol sensitivity with intravenous alcohol self-administration in young adults.Clinical and biological moderators of response to naltrexone in alcohol dependence: a systematic review of the evidence.Addiction pharmacogenetics: a systematic review of the genetic variation of the dopaminergic systemAn integrated genome-wide approach to discover tumor-specific antigens as potential immunologic and clinical targets in cancer.Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues.KCNN Genes that Encode Small-Conductance Ca2+-Activated K+ Channels Influence Alcohol and Drug Addiction.Gene x abstinence effects on drug cue reactivity in addiction: multimodal evidenceMeta-Analysis Reveals Significant Association of the 3'-UTR VNTR in SLC6A3 with Alcohol Dependence.Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 GenotypeInteractive effects of OPRM1 and DAT1 genetic variation on subjective responses to alcohol.Subjective response as a consideration in the pharmacogenetics of alcoholism treatment.Subjective Response to Alcohol as a Research Domain Criterion.Endogenous opioid system: a promising target for future smoking cessation medications.Effects of naltrexone on alcohol self-administration and craving: meta-analysis of human laboratory studies.Experimental psychopathology paradigms for alcohol use disorders: Applications for translational researchA prospective study of genetic factors, human laboratory phenotypes, and heavy drinking in late adolescence.Kv7 channels in the nucleus accumbens are altered by chronic drinking and are targets for reducing alcohol consumption.Alcohol-Induced Stimulation Mediates the Effect of a GABRA2 SNP on Alcohol Self-Administrated among Alcohol-Dependent Individuals.Pharmacogenetic Effects of Naltrexone in Individuals of East Asian Descent: Human Laboratory Findings from a Randomized Trial.Independent and Interactive Effects of OPRM1 and DAT1 Polymorphisms on Alcohol Consumption and Subjective Responses in Social Drinkers.Dopaminergic Genetic Variation Influences Aripiprazole Effects on Alcohol Self-Administration and the Neural Response to Alcohol Cues in a Randomized Trial.Aripiprazole Suppression of Drinking in a Clinical Laboratory Paradigm: Influence of Impulsivity and Self-Control.Promising pharmacogenetic targets for treating alcohol use disorder: evidence from preclinical models.
P2860
Q27021406-2222D169-9C32-4D5D-94CA-43A2584B0D75Q33568294-A6C698B0-933B-49EC-96E5-9D1717E79AF7Q33591091-14BB28F9-4FEB-4216-92A4-20ADF02F8F02Q33752381-2D6589AC-6BA5-4A1A-BF6D-85F0F92C7752Q34806003-B110BEB8-717E-43D8-81CB-FC9DFC888249Q34989821-A46A6CA5-7C93-48A8-9257-35DD5067F405Q35128787-CEC8117A-C35D-4790-99EC-1A7BD4F781BBQ35995415-D08CC754-E03E-4712-AC77-016C9003E462Q36476387-DBD3DB41-DCC6-4F3F-92B8-716890ACF0E5Q36540015-E727ED90-5902-4735-9A15-CCDC84DFB13EQ36821781-77C2671E-C36D-4418-8D07-718B3A2AA481Q36928468-18ADA3CA-CD50-4B05-8E46-5AA55F28C144Q37059211-44B7047F-3254-43D7-BF73-40CC0C90D3A4Q37262791-1B9CC40D-2B9D-4D84-8C59-7CB4A5E1F114Q37712390-7F346CD2-717C-41C6-B330-6E7523055F23Q38464015-8B902510-AE83-4FFD-9FCF-35D9CE3A8C74Q38685941-5B44542B-3FDE-4281-9196-1E0ABEFF8C64Q38747115-D98ADF0B-0930-4407-AF0B-D5943E27197EQ38842262-8D5BB7DF-4427-469D-9FBB-401FCF9543DFQ38856407-3F417710-9F5D-403C-B002-E4EA980B2D84Q38885612-95C0AF5D-42DF-4881-9E2D-419ADE347C4AQ40806344-79668BFE-253E-4391-AE95-32E65CF51B97Q40974818-625ADA92-F839-48EB-9FF0-48642FBE7E58Q47674472-06D752B3-E493-43C9-A571-8B4AB5559F38Q47757423-747B1705-14B0-44AB-A8F6-B435DE12275EQ47843882-5310C46E-189D-4D20-8776-EA86E9691ADDQ47895142-D4D724DA-A3FD-4C4E-810C-CBBD5821B969Q51084128-311A7A80-CE8D-401C-A9B9-C944DE4933D2
P2860
Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Naltrexone modification of dri ...... ne transporter (SLC6A3) genes.
@ast
Naltrexone modification of dri ...... ne transporter (SLC6A3) genes.
@en
type
label
Naltrexone modification of dri ...... ne transporter (SLC6A3) genes.
@ast
Naltrexone modification of dri ...... ne transporter (SLC6A3) genes.
@en
prefLabel
Naltrexone modification of dri ...... ne transporter (SLC6A3) genes.
@ast
Naltrexone modification of dri ...... ne transporter (SLC6A3) genes.
@en
P2093
P2860
P1476
Naltrexone modification of dri ...... ne transporter (SLC6A3) genes.
@en
P2093
Abraham Tiffany
Hugh Myrick
Konstantin K Voronin
Patrick K Randall
Raymond F Anton
P2860
P304
P356
10.1111/J.1530-0277.2012.01807.X
P577
2012-05-02T00:00:00Z